Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$36.52 - $41.46 $212,948 - $241,753
-5,831 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$34.27 - $40.01 $51,336 - $59,934
-1,498 Reduced 20.44%
5,831 $208,000
Q4 2020

Feb 16, 2021

SELL
$34.07 - $39.94 $9.33 Million - $10.9 Million
-273,892 Reduced 97.39%
7,329 $270,000
Q3 2020

Nov 13, 2020

BUY
$38.11 - $42.99 $184,909 - $208,587
4,852 Added 1.76%
281,221 $10.6 Million
Q2 2020

Aug 14, 2020

BUY
$37.87 - $43.58 $3.37 Million - $3.88 Million
89,087 Added 47.57%
276,369 $11.3 Million
Q1 2020

May 15, 2020

BUY
$32.47 - $48.83 $5.9 Million - $8.88 Million
181,788 Added 3308.85%
187,282 $7.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
5,494
5,494 $237,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Capital Bank & Trust CO Portfolio

Follow Capital Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Capital Bank & Trust CO with notifications on news.